FDA OKs drug that offers hope to multiple sclerosis patients
Researcher calls the benefits of ocrelizumab 'quite stunning.'
Researcher calls the benefits of ocrelizumab 'quite stunning.'
After a battle with Guillain-Barré syndrome, Heidi Roine is learning to move again. And live again.